VCAM1 and brain neoplasm: Together, these preclinical and clinical data suggest that VCAM-1–targeted MRI has the potential to augment existing MRI techniques, by exploiting microenvironmental changes at the periphery of brain tumors for greater accuracy of margin delineation, despite an undisrupted BBB.